Baseline characteristics evaluated included age at enrollment, diabetes duration, sex, race/ethnicity, insulin modality (MDI versus CSII), metabolic status (HbA1c, C-peptide, hypoglycemia unawareness status), BMI, presence of nephropathy, education level, and household income. This evidence concerns the gene INS and diabetes mellitus.